The Truth About Ketamine: An Anesthesiologist Explains Drug Safety
Anesthesiologist Jim Ellwood explains that ketamine, like propofol and fentanyl, is safe when administered by trained professionals but becomes dangerous in unregulated settings. He contrasts high‑profile overdose headlines with the controlled, low‑dose protocols used for anesthesia and emerging mental‑health treatments. The piece highlights growing clinical evidence that supervised ketamine can rapidly alleviate treatment‑resistant depression and PTSD. Ellwood also shares his personal positive experience and cautions against conflating therapeutic use with recreational misuse.
A Telehealth Success Story
The San Francisco Tech Council launched a state‑funded program that teaches low‑income, limited‑English‑proficiency patients how to use online medical portals. Participants received a 45‑minute hands‑on session with a digital navigator, enabling them to schedule appointments, view results, and request prescriptions. Feedback...
Pharma Pulse: The Oral GLP-1 Battle and GSK’s Billion-Dollar Breath of Fresh Air
Eli Lilly’s oral GLP‑1 small‑molecule orforglipron demonstrated greater A1C reduction and weight loss than oral semaglutide, while offering flexible dosing without fasting. GSK announced a $950 million acquisition of 35Pharma, securing HS235, an activin‑signaling inhibitor aimed at pulmonary hypertension. The deal taps...
Cowellnex and Metagen Launch Joint Research Utilizing Independently Acquired High‑Precision Gut Microbiota Data
Cowellnex Co., Ltd. and Metagen, Inc. will begin joint research in February 2026 to create new gut‑microbiota test items and a personalized food‑recommendation algorithm using Cowellnex’s three‑year shotgun metagenomic dataset. The partnership leverages Cowellnex’s high‑precision Japanese microbiome data and Metagen’s...
“How Do I Use Lean to Reduce Headcount?” — Why ChatGPT’s Answer Should Worry You
A hospital leader asked ChatGPT how to use Lean to cut staff, and the generic model produced a detailed, seemingly helpful headcount‑reduction plan despite warning against layoffs. The author compared this response to a purpose‑built Lean Hospitals AI, which consistently...
Sun Nuclear QADS 2026 Event Combines Clinical Insight and New Innovations for Advancing Radiation Therapy QA
Sun Nuclear launched its 15th QA & Dosimetry Symposium (QADS) in Rome, gathering more than 230 clinical physicists from nearly 40 countries. The event introduced the Daily QA 4 Pro, a combined dosimetry‑imaging device designed to streamline daily machine quality checks. Demonstrations also...
Amid Boston’s Life Sciences Boom, an Unusual Alliance Orchestrates Technician Training
Boston’s life‑sciences sector is adding thousands of well‑paying technician positions that often don’t require a four‑year degree. To address the fragmented training ecosystem, the city funded the Life Sciences Career Alliance with $4.7 million, appointing Year Up United as the coordinating...
January 2026 Patent Highlights
The January 2026 Patent Highlights roundup spotlights a wave of new intellectual‑property activity across several cutting‑edge drug discovery areas. Notable filings include lysine‑directed covalent inhibitor chemotypes, strategies to balance potency with drug‑like properties, refined target‑selection frameworks, dozens of Polθ synthetic‑lethal patents...
Physician Mental Health and Suicide Prevention: Stories of Survival
The new book Physicians With Lived Experience by Dr. Michael F. Myers compiles personal narratives that illuminate the hidden crisis of physician mental health and suicide. Forewords by Jennifer Breen Feist and Dr. Darrell Kirch highlight the power of storytelling, the passage...
Two More States Are About to Jump Ship Onto Their Own ACA Marketplaces
Oregon and Oklahoma are set to launch their own state‑based ACA exchanges, bringing the total to 23 states (including DC) that will operate independent marketplaces by 2028. This shift will push state‑run exchanges past the 50 percent population mark, a milestone...
The Enduring Value of the Physical Exam in Modern Medicine
Physician Francisco M. Torres argues that the bedside physical exam remains a vital diagnostic tool despite rapid advances in imaging and lab tests. He recounts two personal cases—a misdiagnosed sciatica caused by shingles and a postoperative fluid collection missed without...
From Singapore to Canada: A Blueprint for Primary Care Transformation
A recent OurCare survey found 5.9 million Canadians lack a primary‑care provider, and those with one face long waits and rushed visits, driving emergency‑department crowding. The federal government responded by creating 5,000 Express Entry slots for international doctors, but experts argue...
Most Detailed Spatial Atlas yet for Mapping the Pancreatic Tumor Microenvironment
An international team led by the University of Birmingham, University Hospitals Birmingham NHS Foundation Trust and Bristol Myers Squibb has produced the most detailed spatial atlas of pancreatic ductal adenocarcinoma (PDAC) to date. Using spatial transcriptomics and spatial molecular imaging...
Case Study: A Broken LOI, the Right Advisor, and a Successful Exit
Owners of a concierge medical practice attempted a sale, but the first Letter of Intent (LOI) collapsed, leaving them to restart the process. They turned to Axial's Advisor Finder, which quickly presented four vetted M&A advisors with healthcare expertise. After...
Health Care Price Transparency: Why Patients Are Bypassing Insurance
Dr. Daganzo recounts paying $78 for identical lab tests through a direct‑pay platform versus an estimated $900 cash price at Quest Diagnostics, highlighting extreme price opacity in traditional settings. Patients increasingly bypass insurance‑based pathways, preferring transparent, upfront pricing and predictable...
Opt-In Vs. Opt-Out: How Defaults Shape Organ Donation Rates
The United States still uses an opt‑in organ donation system, meaning individuals must actively register to become donors. Behavioral‑economics research shows that default settings heavily influence decisions, and the opt‑in model creates inertia at points like DMV renewals. Countries that...
YOU(th) Closes US$4.5m Health Screening Round
YOU(th) has secured US$4.5 million to scale its AI‑driven smartphone health‑screening platform, which evaluates over 50 digital biomarkers in under two minutes. The round was led by Callisto Health with participation from caesar., adesso Ventures, Antler, Moonstone, 1024 Ventures and notable...
Post-Holiday Heart Health: How to Reset Your Cardiovascular Habits
The post‑holiday period often reveals hidden cardiovascular strain from excess calories, alcohol, and disrupted sleep. These habits can raise blood pressure, cholesterol, and glucose, creating a short‑term risk window. Men face higher risk due to binge‑drinking patterns and delayed preventive...
Obesity Reduces Lifespan of Offspring
A new study shows that maternal obesity dramatically shortens the lifespan of mouse offspring, even when the pups are switched to a healthy diet after weaning. The reduction in longevity is linked to early‑life epigenetic programming that triggers widespread organ...
Earlier Liver Disease Detection Means Better Outcomes – and You Can Make the Difference
Chronic liver disease in the UK is often identified only after emergency admission, with more than a third of such patients dying within a year. Stigma and competing primary‑care priorities leave up to 80 % of MASH cases undiagnosed, driving rising...
What Does the Rollout of Trump Rx Reveal?
Buzz Health President Joseph Kleiman says TrumpRx is advancing drug‑price transparency by giving consumers early visibility into prescription costs. He notes that real‑time pricing can help patients compare options but also warns that prices are dynamic and may change before...
Leading in the Psychedelic Space: Q&A with Tarek Rabah
Otsuka America became the first major pharmaceutical company to back psychedelic‑inspired medicines in 2020 through a partnership with COMPASS Pathways, and deepened that commitment by acquiring Mindset in 2023. The company is applying its long‑standing CNS expertise to develop serotonergic...
Women’s HealthX Launches in Boston This December to Transform Women’s Health Through Data and Science
Women’s HealthX (WoHX) will convene 750 pharma, biotech, hospital, insurer, startup and government leaders in Boston on December 3‑4, 2026. The two‑day summit aims to close the sex‑difference data gap by showcasing evidence‑based technologies, AI tools and digital therapeutics across the...
Surprise! Fifth Circuit Rejects DEA’s Longstanding Interpretation of a Pharmacist’s “Corresponding Responsibility” And “Usual Course of Professional Practice” Regulations
The Fifth Circuit rejected the DEA’s long‑standing reading of the pharmacist’s “corresponding responsibility” and “usual course of professional practice” regulations, ruling that liability requires proof a prescription was invalid when issued and that the pharmacist actually knew it was invalid....
Breaking: Trump Regime Cuts $260 Million in Medicaid Funds to Minnesota & Stops New Durable Medical Equipment Supplier Enrollment Nationally...
The Centers for Medicare & Medicaid Services (CMS) announced a $259.5 million deferral of federal Medicaid matching funds to Minnesota, citing questionable and potentially fraudulent claims. The agency also imposed a six‑month nationwide moratorium on new enrollment for Durable Medical Equipment,...
Informed Refusal Vs. Denied Care: A Dental Case Study
A dentist refused to perform a routine cleaning without bitewing X‑rays, despite the patient’s low‑risk status and recent radiographs. The practice cited a two‑year imaging policy and warned that proceeding could jeopardize the hygienist’s license. After consulting the supervising dentist,...
Dotinurad (FYU-981)
Dotinurad (FYU‑981), marketed as Urece®, is a URAT1 inhibitor approved for gout and hyperuricemia in Japan and China. The drug was chemically refined from the older uricosuric benzbromarone to retain potency while eliminating rare hepatotoxic events. Crystalys Therapeutics is now...
A Review of Efforts to Develop Stem Cell Therapies for Neurodegenerative Conditions
Stem cell therapies for neurodegenerative diseases span unregulated, low‑evidence clinics to proprietary, patent‑protected programs seeking regulatory approval. A new narrative review compiles trial outcomes, highlighting modest benefits—primarily brief inflammation reduction—and significant variability across patients and cell batches. The paper also...
Rare Disease Day Insight: Epilepsy Care Gaps in Pregnancy with UCB’s Andrea Wilkinson — Episode 244
The Xtalks Life Science Podcast’s Episode 244 spotlights a persistent gap in epilepsy care for pregnant women, noting that fewer than 5% of clinical trials include this population. Andrea Wilkinson, UCB’s Global Head of Patient Engagement & Advocacy, discusses new...
Pharmaceutical Executive Daily: FDA Approves Braftovi
The FDA has approved Braftovi for patients with BRAF V600E‑mutant metastatic colorectal cancer, expanding targeted options in a genetically defined subset. The clearance underscores the momentum of biomarker‑driven oncology and combination‑therapy strategies. In parallel, Novo Nordisk announced a $2 billion partnership with Vivtex...
Menopausal Hormone Therapy Does Not Increase Mortality
A Danish register study of over 800,000 women examined the long‑term safety of menopausal hormone therapy (MHT). About 12% of participants used MHT for a median of 1.7 years, and the analysis found no association between MHT use and all‑cause...
Medicines and Healthcare Products Regulatory Agency Confiscates 2,000 Doses of Illegal Weight-Loss Drugs: Report
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) seized nearly 2,000 doses of illegal weight‑loss drugs in raids on sites in Lincolnshire and Nottinghamshire, marking its second major operation in four months. The confiscated products were labelled as containing tirzepatide...
60 Million Reasons to Pay Attention: The Investment Thesis Behind Chamber Cardio’s Series A
Chamber Cardio announced a $60 million Series A round in February 2026, led by Frist Cressey Ventures and backed by General Catalyst, Optum Ventures, Healthworx and other investors. The startup offers a two‑sided platform that connects payers with cardiology practices, embedding workflow‑native AI...
Insulin Resistance Is Not a Disease: A Metabolic Reframe
Type 2 diabetes is reframed as chronic elevated blood sugar (CEBS) rather than a disease of insulin deficiency. The article argues that what is labeled "insulin resistance" is a protective cellular response to persistent glucose oversupply caused by excessive carbohydrate consumption....
A Remedy for Medicine Procurement: How Brazil Is Improving Decision-Making in a $75 Billion Market Using Open Data and AI
Brazil spends roughly US$75 billion annually on medicines through its universal health system, but fragmented procurement across 5,000 municipalities creates price volatility and opaque documentation. A coalition of government agencies and civil‑society groups launched the Medicamentos Transparentes platform, which consolidates purchase...
Beyond Vitals Spot Checks: Sibel Health and LookDeep Health Combine Wearable Monitoring with Real-Time Bedside AI
Sibel Health and LookDeep Health announced a strategic partnership that merges Sibel’s FDA‑cleared ANNE® One wearable, which continuously captures clinical‑grade vitals, with LookDeep’s aimee™ bedside AI that adds real‑time visual and audio context. The combined platform targets emergency departments, general...
From Glucose to Vascular Health: The Future of Diabetes Care
Diabetes prevalence has surged past 800 million adults, with youth type 2 rates climbing 94 % since 1990, intensifying vascular complications like peripheral artery disease. Surveys reveal 55 % of Americans delay seeking care for leg pain and 80 % of primary‑care clinicians lack confidence...
When Innovation Gets Stuck: Humanity at the Core
A Parallels survey of 600+ global IT leaders found 94% fear vendor lock‑in, especially in health systems where platforms now underpin clinical, security and data functions. The study shows a shift from cost‑avoidance to protecting organisational freedom, prompting hybrid and...
Digital Health Rewired 2026 Programme Published
The Digital Health Rewired 2026 conference programme, featuring ten themed stages, has been released. More than 300 senior health‑IT leaders, including NHS CEOs, CIOs, CCIOs and CNIOs, will present sessions on digital transformation, cyber security, AI, and electronic patient records....
Tooth Whitening without Enamel Damage? Vibration-Activated Powder Protects Pearly Whites for Better Oral Health
Researchers at Shanghai Xuhui District Stomatological Hospital and the Chinese Academy of Sciences have engineered a vibration‑activated teeth‑whitening powder (BSCT) that works with electric toothbrushes. The ceramic powder uses piezoelectric catalysis to generate reactive oxygen species for stain removal while...
Healthcare AI Shifting From Pilot to Profit, Report Finds
NVIDIA’s second State of AI in Healthcare report shows AI moving from experimentation to profit across radiology, drug discovery, medical devices and digital twins. Seventy percent of respondents now actively use AI, up from 63% a year earlier, and 69%...
The Brain as the Rate-Limiting Organ for Longevity
The article argues that the brain is the rate‑limiting organ for longevity, asserting that neural network degradation drives functional decline across the body. While peripheral organ rejuvenation has advanced, preserving and repairing brain tissue remains the critical bottleneck. It proposes...
FDA Enforcement on Copycat GLP-1's Could Reshape Retail Pharmacy Economics: Q&A with David Graziano
The FDA’s crackdown on non‑approved or “copycat” GLP‑1 drugs is expected to push patients toward FDA‑approved therapies, elevating the role of retail pharmacies as primary access points. GoodRx’s head of retail network, David Graziano, says the company’s cost‑plus pricing model...
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy
Mevion Medical Systems announced that its S250‑FIT proton therapy system has received CE marking under EU MDR, allowing marketing and clinical use across the European Union. The compact, LINAC‑vault‑ready platform, already cleared by the U.S. FDA, fits into standard radiation...
Carea Launches Support Platform for Complex Fertility Treatment
Carea has introduced a new "Trying to Conceive: IVF/IUI" mode within its pregnancy and postnatal wellbeing app, offering a day‑to‑day support system for women undergoing fertility treatment. The feature includes a personalised medication tracker, video guides, reminders, and a visual...
Sleep Cycle and Carnegie Mellon to Explore Sleep Data to Detect Outbreaks
Sleep Cycle and Carnegie Mellon University's Delphi Group have launched a five‑year research collaboration to test whether privacy‑preserved sleep data—particularly nightly cough intensity captured by Sleep Cycle’s Cough Radar—can augment traditional respiratory disease surveillance. The partnership will share de‑identified data...
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position...
Galderma announced that regulatory agencies in the European Union, United States and Canada have approved a new state‑of‑the‑art Restylane® syringe for use with its NASHA® lidocaine filler line. The device is cleared for a broad set of facial areas—including cheeks,...
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT
HekaBio K.K. and Alpha Tau Medical have secured Japanese regulatory approval for Alpha DaRT, a diffusing alpha‑radiation therapy for unresectable locally advanced or recurrent head‑and‑neck cancer. The approval makes Japan the first country outside Israel to clear the device, positioning HekaBio...
Filkri Becomes Fifth FDA-Approved Neupogen Biosimilar
Accord BioPharma’s Filkri (filgrastim‑laha) received FDA approval as the fifth biosimilar to Amgen’s Neupogen. The indication set mirrors Neupogen’s, covering chemotherapy‑induced neutropenia, AML, bone‑marrow transplant, severe chronic neutropenia, and radiation‑induced syndrome. Approval was based on two randomized trials in healthy...
The Vascular Surgeon Shortage: Why Amputations Are Rising
The United States faces a critical vascular surgeon shortage that is directly fueling a rise in preventable amputations. Only about 5,800 vascular surgeons practice today, while the current demand exceeds 8,000 and is projected to reach 9,000 within a decade...